ライフサイエンスコーパス: Cre recombinase

1 modelled by confined injection of adenoviral Cre recombinase.

2 ression are activated only after exposure to Cre recombinase.

3 27-bp cten promoter drives the expression of Cre recombinase.

4 h cell or tissue type-specific expression of Cre recombinase.

5 which Notch activation is induced in HSCs by Cre recombinase.

6 NIP isoform conditionally in the presence of Cre recombinase.

7 .4 kb promoter, and followed cell fates with Cre recombinase.

8 Rev3L could be conditionally inactivated by Cre recombinase.

9 blocker (loxTB), but could be reactivated by Cre recombinase.

10 cardiac-specific activation of the MerCreMer Cre recombinase.

11 AND We engineered a Hand1 allele expressing Cre recombinase.

12 interrupting reporter cassette is excised by Cre recombinase.

13 al allele of Lig3 that could be deleted with Cre recombinase.

14 optical voltage sensor under the control of Cre recombinase.

15 targeted to the early DCT using a DCT-driven Cre recombinase.

16 tantly, can be conditionally expressed using Cre recombinase.

17 disrupted in 2 different strains of mice via cre recombinase.

18 se line with sebocyte-specific expression of Cre recombinase.

19 essing (VIP+) GABAergic interneurons express Cre recombinase.

20 atty acid binding protein 4) promoter-driven Cre-recombinase.

21 tion of an adeno-associated virus expressing Cre recombinase (AAV-Cre) into the midbrain/pons of mice

22 nt adeno-associated viral vectors containing Cre recombinase (AAV-Cre).

23 ter fragment or by targeted integration of a Cre recombinase-activatable expression cassette driven b

24 isynaptic circuit, we constructed a panel of Cre recombinase-activated pseudorabies viruses (PRVs) th

25 ion of these lineages was only observed with Cre recombinase activation during early lung development

26 cent Tomato (Tmt) signal in cells containing Cre recombinase activity.

27 variably diminished (likely due to variable Cre-recombinase activity), but an overabundance of branc

28 eral microinjection of adenovirus-expressing Cre-recombinase (Ad-Cre).

29 Accordingly, adenoviral Cre recombinase (AdCre)-treated LSL-Kras/Irs-1(fl/fl) (K

30 nt replication-deficient adenovirus carrying Cre recombinase (AdCre).

31 serum albumin gene promoter/enhancer-driven Cre recombinase (albCre) transgene was used to investiga

32 approach also mediated efficient delivery of Cre recombinase and Cas9:sgRNA complexes into the mouse

33 l in mice by introducing a fusion protein of Cre recombinase and estrogen receptor (CreER) into the c

34 ated viral vectors containing genes encoding Cre recombinase and green fluorescent protein were micro

35 synthetic sequence through the action of the Cre recombinase and no competition from homologous recom

36 one oncogene (KRAS), achieved by delivering Cre recombinase and sgRNAs, which caused rapid lung tumo

37 sing adeno-associated viral vectors encoding Cre recombinase and short hairpin RNA against Crb2.

38 hod RecWay assembly, as it makes use of both Cre recombinase and the commercially available Gateway c

39 t (KO) mouse lines, with viral expression of Cre-recombinase and a light-activated ion channel for op

40 , such as various fluorescent protein, Gal4, Cre-recombinase and dominant-negative receptor construct

41 However, breeding with a Cre-recombinase and/or Flp-recombinase mouse is required

42 ockdown, GRK2 gene deletion (GRK2(flox/flox)/cre recombinase) and overexpression of GRK2 and its regu

43 be labeled and manipulated, by expression of Cre recombinase, and demonstrated that Hes1(+) CACs do n

44 nsfected cells) can be achieved when Flp and Cre recombinases are expressed as Flp-2A-Cre and Flp-IRE

45 c markers (Sox2 and T) and tamoxifen-induced Cre recombinase-based lineage tracing to locate putative

46 Using Cre recombinase-based lineage tracing, we show that thes

47 Cre recombinase-based, genetic fate-mapping of larval or

48 bryonic endothelium stage (using VE-cadherin-Cre recombinase), but not from embryonic hematopoietic c

49 Because the presence of CRE recombinase can adversely affect the physiology of n

50 Cre recombinase catalyzes the cleavage and religation of

51 letion of Pten and Grp78 mediated by Albumin-Cre-recombinase (cP(f/f)78(f/f)).

52 pha) mouse line and a gene construct driving Cre recombinase (Cre) expression in NSP cells, led to in

53 mouse strains have been developed, in which Cre recombinase (Cre) expression is driven by an RPE-spe

54 nd the marker GFP in the hippocampus of GFAP-Cre recombinase (Cre) mice.

55 Cre recombinase (Cre) mouse driver lines in combination

56 ciated trauma or the toxicity of the chronic Cre recombinase (Cre) produced by the AAV-Cre.

57 Here, we generated knock-in mice expressing Cre recombinase (Cre) under the control of the endogenou

58 in the lung by nasal delivery of adenoviral Cre recombinase (Cre), here we show that KRAS(G12D) expr

59 In this study, we used the Cre recombinase (Cre)-loxP system under regulation of th

60 Finally, we validated that Cre recombinase (Cre)-mediated excision led to functiona

61 m by injecting an adenoviral vector encoding Cre recombinase (Cre)-regulated farnesylated green fluor

62 breeding these mice with lines that express Cre-recombinase (Cre) in early embryogenesis (EIIa-Cre)

63 pulse-labeled using the tamoxifen-dependent Cre recombinase, CreER(T2), expressed from the endogenou

64 or 1 (Tff1) gene and the tamoxifen-inducible Cre recombinase (CreERT2)-coding sequence.

65 describe a technique based on a destabilized Cre recombinase (DD-Cre) whose activity is controlled by

66 (+) .Foxo1 (L/L) mice with lineage-specific Cre recombinase deletion of floxed FOXO1 and compared th

67 hod that exploits GFP for gene manipulation, Cre recombinase dependent on GFP (CRE-DOG), a split comp

68 This strategy relies on CRE recombinase-dependent activation of an EGFP-tagged L

69 onal band of Broca cholinergic neurons using Cre recombinase-dependent adeno-associated virally media

70 Optogenetic stimulation using cre recombinase-dependent ChIEF-AAV-DJ expressed in ARC

71 ng of SOM-expressing neurons in s. oriens, a Cre recombinase-dependent construct for channelrhodopsin

72 probe within a locus designed for efficient Cre recombinase-dependent expression.

73 s nicotine reward behaviors, we engineered a Cre recombinase-dependent gene expression system to sele

74 ermine MN-enriched miRNA expression, we used Cre recombinase-dependent miRNA tagging and affinity pur

75 Here we describe a Cre recombinase-dependent, anterograde transneuronal tra

76 a genetically tagged mouse model carrying a Cre-recombinase-dependent conditional allele of constitu

77 To address this, we used a Cre-recombinase-dependent viral vector approach to expre

78 le gene deletion system based on a dimerised Cre recombinase (diCre) to target CRK3 and elucidate its

79 PR/Cas9 to facilitate use of the dimerisable Cre-recombinase (DiCre) that is frequently used to media

80 Inducible Cre recombinase-directed inactivation of the FAS gene in

81 Because the mechanism of Cre recombinase does not conform to a simple kinetic sch

82 ingly, cells targeted by tamoxifen-inducible cre recombinase driven by nestin enhancer (Nes-creER) in

83 ngineered mouse model in which expression of Cre recombinase driven by the C-type lectin domain famil

84 constitutive activation of betacatenin using cre recombinase driven by the DEAD (Asp-Glu-Ala-Asp) box

85 ating alpha7nAChR(flox) with mice expressing Cre recombinase driven by the glial acidic fibrillary pr

86 generated the Mchr1-cre mouse that expresses cre recombinase driven by the MCHR1 promoter and crossed

87 s mouse strain to transgenic mice expressing Cre recombinase driven by the megakaryocyte (MK)-specifi

88 Using animals expressing Cre recombinase driven by the Six2 promoter, we generate

89 nt marker into the VTA of male mice that had Cre-recombinase driven by OTR gene expression.

90 (IR), IGF-1 receptor (IGF1R), or both using Cre-recombinase driven by the adiponectin promoter.

91 Here we use Cre-recombinase driven by the CNP promoter to generate a

92 p53 and Rb were selectively abrogated using Cre-recombinase driven by the renin promoter.

93 diated by KOR on DA terminals, we utilized a Cre recombinase-driven mouse line lacking KOR in DA neur

94 These include a line for conditional Cre-recombinase-driven inactivation of the gene; a line

95 The collection of over 250 BAC Cre-recombinase driver lines produced by the GENSAT proj

96 used two different mature RPE cell-specific Cre recombinase drivers to inactivate either Dicer1 or D

97 oral activation by tamoxifen (TAM)-inducible Cre recombinase Ela-CreERT in the submandibular gland (S

98 Here, through the use of Cre-recombinase-enabled, cell-specific neuron mapping te

99 Injection of Cre recombinase-encoding adenovirus (AdCre) in the ovari

100 n the ROSA26R reporter mouse model utilizing Cre recombinase-encoding recombinant viruses harboring d

101 olerant mice; and (3) Tag-activation through Cre recombinase-encoding viruses in the liver and HCC de

102 of Optopatch constructs is controlled by the Cre-recombinase enzyme.

103 pocytes prior to cold exposure, using Pdgfra-Cre recombinase estrogen receptor T2 fusion protein (Cre

104 ng growth factor-beta (TGF-beta) mediated by Cre recombinase expressed early in T cell development le

105 expressing a tamoxifen-inducible variant of Cre recombinase expressed under control of the Npr2-prom

106 ory neurons of the postnatal forebrain using Cre recombinase expressed under the control of the alpha

107 ed mouse, and then crossed this mouse with a Cre recombinase expressing mouse driven by the human gli

108 oblasts with 2 different tamoxifen-inducible Cre recombinase-expressing gene-targeted mouse lines.

109 Using a Cre recombinase-expressing IAV, we have previously shown

110 allowed the identification of synapses from Cre recombinase-expressing or GAL4-expressing neurons in

111 neurons chemogenetically using a retrograde Cre-recombinase-expressing canine adenovirus-2 in combin

112 ic Cre strain for RPE gene function studies, Cre recombinase expression alone leads to RPE dysfunctio

113 te-tracing model based on timed and specific Cre recombinase expression and marker gene activation in

114 x/flox) embryos and rendered pikfyve-null by Cre recombinase expression displayed severely reduced DN

115 lidation of a transgenic mouse line in which Cre recombinase expression has been targeted to cells ex

116 ion of floxed KOR or floxed p38alpha MAPK by Cre recombinase expression in dopaminergic neurons block

117 Infected cell tagging by viral Cre recombinase expression in floxed reporter gene mice

118 system largely depends on the specificity of Cre recombinase expression in targeted stem or progenito

119 Using viral-mediated Cre recombinase expression in the NAc of single- or doub

120 Keratin 14-mediated Cre recombinase expression induced expression of MCPyV T

121 ducible membrane-bound reporter and targeted Cre recombinase expression to a subset of glial progenit

122 bone osteocytes, no differences in Mbtps1 or cre recombinase expression were observed in cKO SOL, exp

123 After Cre recombinase expression, GsD is activated temporally

124 cells, and mature keratinocytes through OX40-Cre recombinase expression.

125 h tamoxifen-inducible smooth muscle-specific Cre recombinase expression.

126 hat were crossed with DAT-Cre mice, in which Cre- recombinase expression is under dopamine transporte

127 Cre-recombinase expression in C1 neurons of AT(1A)R-flox

128 By electroporating a cre-recombinase expression vector into the cortex of E13

129 coincided with a progressive loss of hepatic cre-recombinase expression.

130 Fig4 and crossed it with mice expressing the Cre recombinase from the neuron-specific synapsin promot

131 regions, we used transgenic mice expressing Cre recombinase from the Nkx2.1 promoter to ablate loxP-

132 ed cMyBP-C alleles and a tamoxifen-inducible Cre-recombinase fused to 2 mutated estrogen receptors to

133 Notably, TAxI-Cre recombinase fusion proteins induced selective recomb

134 We generated VLPs that contain Gag-Cre recombinase, Gag-Fcy::Fur, and Gag-human caspase-8 a

135 stem to excise the selectable marker and the cre recombinase genes from transgenic banana cv. 'Grande

136 enic lines expressing a controllable form of Cre recombinase have become valuable tools for manipulat

137 Using Cre recombinase, here we show that either deletion or re

138 ouse lines, Wnt1-Cre and P0-Cre that express Cre recombinase in a NC-specific manner, in combination

139 Mice expressing Cre recombinase in cones were bred to mice with a floxed

140 l La allele and used it in mice that express Cre recombinase in either B cell progenitors or the fore

141 system, in conjunction with mice expressing Cre recombinase in either parvalbumin-positive, somatost

142 tion by Cre recombinase in mice that express Cre recombinase in GABAergic neurons.

143 validated a transgenic mouse line expressing cre recombinase in histidine decarboxylase-expressing ne

144 is used to specifically and inducibly drive Cre recombinase in ICC as a strategy to study GIST patho

145 Using mice expressing Cre recombinase in MC4R neurons, we demonstrate bidirect

146 fluorescent protein following activation by Cre recombinase in mice that express Cre recombinase in

147 pocampal CA1 neurons using viral delivery of Cre recombinase in mice.

148 ut mice with a knock-in mouse expressing the Cre recombinase in the CD45 locus.

149 We observe a broad expression of Cre recombinase in the Gfi1(Cre) mouse neonatal inner ea

150 o-associated viral (AAV) vector carrying the Cre recombinase in the hippocampus of mTORf/f mice recap

151 o explained in part by ectopic expression of Cre recombinase in the hypothalamus.

152 Z mice with transgenic mice that express the Cre recombinase in the pancreas, under control of the Pd

153 ntly translated into full-length, functional Cre recombinase in the presence of nonsense suppressors

154 porter showed that recombination mediated by cre recombinase in the Wt1(creEGFP) line occurs randomly

155 expression in the NAc of mice transgenic for Cre recombinase in these MSN subtypes.

156 ggered by intravenous adenoviral delivery of Cre recombinase in transgenic mice expressing the hepato

157 line was assessed on interneurons expressing Cre recombinase in vasoactive intestinal peptide (VIP) o

158 ediated delivery of functional pDNA encoding Cre recombinase in vivo to tissues in transgenic Cre-lox

159 ocalized infusions of adeno-associated virus Cre-recombinase in adult, targeted knock-in mice with lo

160 The Ntsr1-Cre GN220 mouse expresses Cre-recombinase in corticothalamic (CT) neurons in neoco

161 roligins by stereotactic viral expression of Cre-recombinase in hippocampal CA1 region pyramidal neur

162 tamoxifen-inducible collagen type 2a1-driven Cre recombinase increased proliferation and beta-catenin

163 development of a transgenic mouse line where Cre-recombinase-induced expression of a mutant methionyl

164 e (MAPK) was selectively inactivated by AAV1-Cre-recombinase infection in specific brain regions or b

165 t two-hybrid method, CrY2H-seq, which uses a Cre recombinase interaction reporter to intracellularly

166 also used to deliver the biologically active Cre recombinase into a loxP-reporter T cell line.

167 oinflammation in the DR by viral delivery of Cre recombinase into interleukin (IL)-1beta(XAT) transge

168 rom lentiviral delivery of shRNAs along with Cre recombinase into lungs of Loxp-stop-Loxp-KRas mice.

169 letion of Pbx1 by retroviral transduction of Cre recombinase into Pbx2-deficient SVZ stem and progeni

170 Furthermore, introduction of Cre recombinase into primary cortical cultures prepared

171 pproximately E11.5) we have therefore used a Cre recombinase introduced at the Ins1 locus.

172 transgenic Cre line, in which expression of Cre recombinase is controlled by a previously identified

173 of numerous transgenic mouse lines in which Cre recombinase is expressed under the control of organ-

174 ne targeting using the bacteriophage-derived Cre recombinase is widely applied for functional gene st

175 ell adhesion in vivo, we utilized keratin-14 cre-recombinase (K14-cre) to inactivate Flcn in the mous

176 ry epithelium of an ErbB2 model coexpressing Cre recombinase led to accelerated tumor onset.

177 itional En mutants with floxed alleles and a cre recombinase line that becomes active in postmitotic

178 We identified a particular Cre-recombinase line that acts in the cortical primordiu

179 n-inducible disruption of Trpm7 and multiple Cre recombinase lines, we show that Trpm7 deletion befor

180 These studies combine the use of the Cre-recombinase/loxP system in mice with optogenetics to

181 In the presence of activated Cre recombinase, luciferase activity, and by proxy, HPV

182 tes in a cultured pre-B cell line as well as Cre recombinase-mediated Bcl11a(lox/lox) deletion in exp

183 This uses Cre recombinase-mediated cassette exchange to insert a c

184 Here, we used a Cre recombinase-mediated chromosome loss strategy to ind

185 events in preclinical mouse models requires Cre recombinase-mediated conditional gene expression in

186 n of Panx1 (Panx1 (-/-) Apoe (-/-) ) or with Cre recombinase-mediated deletion of Panx1 in endothelia

187 We show that Cre recombinase-mediated DT-A ablation selectively elimi

188 Cre recombinase-mediated excision of the stop cassette l

189 We have also used Cre recombinase-mediated expression of channelrhodopsin-

190 ducible lineage tracing to fate map, through Cre recombinase-mediated fluorescent reporter gene activ

191 By using temporal Cre recombinase-mediated gene deletion to ablate SAP exp

192 h CreMaster mice, which are characterized by Cre recombinase-mediated mast cell eradication.

193 Previous studies have demonstrated that Cre recombinase-mediated recombination can lead to combi

194 ic recombination system based on dimerizable Cre recombinase-mediated recombination in the apicomplex

195 nger needed after integration was excised by Cre recombinase-mediated recombination of lox sites.

196 By Cre recombinase-mediated removal in oocytes of the micro

197 y" activated AR transgene expression through Cre recombinase-mediated removal of the LSL cassette.

198 eage tracings using cyclization recombinase (Cre) recombinase-mediated cell labeling represent the go

199 ion of Steroidogenic Factor-1 (SF1) to drive Cre-recombinase-mediated deletion of the brain muscle ar

200 centrosome amplification can be induced by a Cre-recombinase-mediated increase in expression of Polo-

201 Cre-recombinase-mediated knockdown and overexpression of

202 Cre-recombinase-mediated Ptch1 ablation in mammary epith

203 h various neurone selective, promoter-driven Cre recombinase mice resulted in GCaMP3 expression in de

204 can be controlled tissue-specifically using Cre recombinase mice.

205 26-lox-STOP-lox-miR-150 mice with WAP-driven Cre recombinase mice.

206 pment we crossed Myh9 floxed mice and Nkx2.5 cre-recombinase mice.

207 ty in mice and develop a new tissue specific Cre recombinase mouse model, we have established pCTEN-C

208 combinase (thrombopoietic deletion) or Cd11b-Cre-recombinase (myeloid deletion).

209 onsense mutation into the coding sequence of Cre recombinase (nsCre).

210 Upon activation with Cre recombinase ("on-state"), the intron is crippled and

211 anterograde tracing using mice that express Cre recombinase only in neurons producing acetylcholine,

212 A complementary DNA encoding either Cre recombinase or a tamoxifen-inducible MerCreMer chima

213 d nanoparticles with negatively supercharged Cre recombinase or anionic Cas9:single-guide (sg)RNA com

214 lleles are revertible in somatic tissues via Cre recombinase or splice-site-blocking morpholinos and

215 Recently, using the Flp-Cre recombinase pair, dual RMCE proved to be efficient,

216 nanoparticles (MSNs) as carriers to deliver Cre recombinase protein into maize (Zea mays) cells.

217 ify mutations in the dimerization surface of Cre recombinase (R32V, R32M and 303GVSdup) that improve

218 tegrase system in place of the bidirectional Cre recombinase reaction; and (iii) gel extraction by DN

219 o achieve constitutive HH signaling) using a Cre recombinase regulated by the lysozyme M promoter.

220 Cre recombinase, regulated by the pancreatic transcripti

221 These mice were crossed with mice expressing Cre recombinase, regulated by the villin or CD11c promot

222 in postnatal testis, and a dual fluorescent Cre recombinase reporter to label FLC and ALC in vivo.

223 Stra8 (mcKO) and Zp3 (fcKO) promoter-driven Cre recombinase, respectively.

224 tionally restore or delete CRHR1 via Flp and Cre recombinase, respectively.

225 rt1 gene to mice expressing CD4-cre or Foxp3-cre recombinase, respectively.

226 d disruptive sequence that can be deleted by Cre recombinase, resulting in restored IL-1R1 gene expre

227 ated Vps34(f/f) mice, in which expression of Cre recombinase results in a deletion of exon 4 of Vps34

228 trogradely transported AAV vector expressing Cre recombinase (Retro-Cre-GFP) into the BLA (Experiment

229 developed a recombinant JHMV that expresses Cre recombinase (rJ-Cre) and infected mice that universa

230 eceptor (Lepr) was selectively ablated using Cre-recombinase selectively expressed in the hindbrain u

231 cells using smooth muscle protein 22-driven Cre recombinase (SMGRKO mice) and compared them with mic

232 h an adenoassociated viral vector expressing Cre recombinase specifically in hepatocytes.

233 Using the mice expressing Cre recombinase specifically in the lens epithelial cell

234 s with mouse lines that ubiquitously express Cre recombinase starting early in development (e.g. MeuC

235 We used a tamoxifen-regulated Cre recombinase system to conditionally express the HPV

236 Using a cardiac-specific inducible Cre recombinase system, Cav1.2 mRNA was reduced to 11 +/

237 Using the CD19(Cre) recombinase system, we normalized expression of TLR

238 h PPARgamma was depleted using an adenovirus-Cre-recombinase system and in which adiponectin was also

239 combined with a split-intein-mediated split-Cre-recombinase system in mice to isolate, characterize,

240 the potent delivery of nM concentrations of Cre recombinase, TALE- and Cas9-based transcription acti

241 mary sarcomas generated with CRISPR-Cas9 and Cre recombinase technology had similar histology, growth

242 1(CreER) mice expressing tamoxifen-inducible Cre recombinase that allow for specific manipulation of

243 nic mouse under the control of both Flp- and Cre-recombinases that is an effective tool for circuit m

244 In cells expressing Cre-recombinase, the floxed sequence is deleted, resulti

245 ce were crossed with mice transgenic for Pf4-Cre-recombinase (thrombopoietic deletion) or Cd11b-Cre-r

246 cinar cell-specific expression of knocked-in Cre recombinase through control of aquaporin 5 (Aqp5) pr

247 tability was mimicked with viral delivery of Cre recombinase to astrocytes in the LHA and rescued by

248 mbens with adeno-associated virus expressing Cre recombinase to create focal, homozygous Hdac3 deleti

249 lpha subunit and cell-specific expression of Cre recombinase to deplete PV(+) or SST(+) interneurons

250 After viral delivery of Cre recombinase to hepatocytes in vivo, GsD is expressed

251 itutively active ROSA26 locus in response to Cre recombinase to study the role of these phosphorylati

252 nd Probasin(Cre) alleles drive expression of Cre recombinase to the prostate epithelium and periepith

253 l recombinase technology using both FlpO and Cre recombinases to generate primary sarcomas in mice wi

254 kout mouse model using progesterone receptor-Cre-recombinase to achieve Pten and Grp78 (cPten(f/f)Grp

255 ation with adeno-associated virus expressing Cre-recombinase to generate focal homozygous deletions o

256 ice with selective expression of tdTomato or cre recombinase together with optogenetics to investigat

257 ice with a retinoid acid receptor 2 promoter-Cre recombinase transgene (Rarb-cre) expressed in embryo

258 ock-out mice carrying an aP2 promoter-driven Cre recombinase transgene showed a blunted response to t

259 KD1 gene and heterozygous for an aquaporin-2-Cre recombinase transgene to achieve collecting duct-spe

260 C transgenic mice with a tamoxifen-inducible Cre recombinase transgenic line, CAGGS-Cre-ER.

261 kout (floxed) Ptpn11 allele (Ptpn11(fl)) and Cre recombinase transgenic mice to delete Ptpn11 specifi

262 onditional knockout [cKO]) when crossed with Cre recombinase transgenic mice.

263 and alpha-myosin heavy-chain promoter-driven Cre recombinase transgenic mice.

264 t nervous system using a tamoxifen inducible Cre recombinase transgenic mouse system.

265 artifacts associated with beta-cell-specific Cre-recombinase transgenic models, raising questions abo

266 using mice that express tamoxifen-inducible Cre recombinase under control of osteopontin regulatory

267 hemiparkinsonian transgenic mice expressing Cre recombinase under control of the choline acetyltrans

268 IF-1alpha floxed mice with mice that express Cre recombinase under control of the glial fibrillary ac

269 U.1) was conditionally deleted in B cells by Cre recombinase under control of the Mb1 gene in Spib (e

270 erated mice that express tamoxifen-inducible Cre recombinase under control of the Plp1 promoter and c

271 n-C null mice and transgenic mice expressing Cre recombinase under control of the S100A4 promoter cro

272 ite cells in mice, using tamoxifen-inducible Cre recombinase under control of the satellite cell-spec

273 ells using mouse BAC transgenes that express Cre recombinase under strict regulatory control.

274 neered the expression of tamoxifen-inducible Cre recombinase under the control of a kidney-specific p

275 Using transgenic mice expressing Cre recombinase under the control of either the dopamine

276 xpression in specific cell types, expressing Cre recombinase under the control of large genomic regul

277 yn(flox/flox) animals with mice carrying the Cre recombinase under the control of the Cd79a promoter,

278 mice with CX3CR1(CreER) mice, which express Cre recombinase under the control of the CX3C chemokine

279 lele of Pak4 with transgenic mice expressing Cre recombinase under the control of the nestin promoter

280 th muscle in Brg1(flox/flox) mice expressing Cre recombinase under the control of the smooth muscle m

281 manipulated in knock-in mice expressing the Cre recombinase under the endogenous parvalbumin promote

282 he circadian clock gene Bmal1 and expressing Cre recombinase under the endogenous Renin promoter (Bma

283 ZW-X mouse line with a mouse that expresses Cre recombinase under the influence of the NPY promoter.

284 leles floxed at exon 1 to animals expressing Cre recombinase under the pre-proglucagon promoter.

285 crossing FKRP(KD) mice with those expressing Cre recombinase under the Sox1 promoter.

286 allele using transgenic mice that expressed Cre-recombinase under control of the ubiquitous CAG prom

287 Adult transgenic mice expressing cre-recombinase under the choline acetyltransferase prom

288 e using an adeno-associated virus serotype-9 Cre recombinase vector (AAV.CBA.Cre).

289 ection of a BAAV vector encoding a bacterial Cre recombinase via canalostomy in adult mice with floxe

290 IL-22-expressing cells, a sequence encoding Cre recombinase was cloned into the Il22 locus, and IL22

291 ible system in which an optimized variant of Cre recombinase was expressed under the control of the V

292 delity lineage tracing after confirming that Cre recombinase was mesothelial specific and faithfully

293 Adenoviral Cre recombinase was used to delete RISP from isolated PA

294 ssibility that the bovine K5 promoter-driven Cre-recombinase was active early in trophoblast-lineage

295 tor cells with adenovirus expressing GFP and Cre-recombinase was successful in GRP78 ablation, and th

296 us from cells, Tre, an engineered version of Cre recombinase, was designed to target a 34-bp sequence

297 Using Cre recombinase we swapped a target 126-kb segment of th

298 an adeno-associated viral vector coding for Cre recombinase, we found that focal restoration of OX2R

299 intestinal immune cells using a CD11c-driven Cre recombinase, which decreased anti-inflammatory media

300 ing fluorescent parasite strains that inject Cre recombinase with their rhoptry proteins (Toxoplasma-